Back to search

Article

Prevalence and factors associated of metabolic syndrome in first- treatment drug-naïve schizophrenia patients: a large-scale cross- sectional study

2023-03-20

Abstract excerpt

<h4>Background: </h4> Patients with schizophrenia are at high risk of developing metabolic disorders, even prior to exposure to antipsychotic medication. The aim of this paper is to report on the prevalence of MetS in first-treatment drug-naïve schizophrenia patients and to further analyze the factors influencing of the MetS. <h4>Methods: </h4> A total of 668 patients with first-treatment drug-naïve schizophrenia...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f15d297e-f47c-5506-8946-f1180b7340c3
DOI
10.21203/rs.3.rs-2662867/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prevalence and factors associated of metabolic syndrome in first- treatment drug-naïve schizophrenia patients: a large-scale cross- sectional studyDOI 10.21203/rs.3.rs-2662867/v1
Gender differences in prevalence and associated factors of metabolic syndrome in first-treatment and drug-naïve schizophrenia patientsSemantic proximity
A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.Semantic proximity
Genetic predisposition and antipsychotic treatment effect on metabolic syndrome in schizophrenia: a ten-year follow-up study using the Estonian BiobankSemantic proximity
The relationship between brain-derived neurotrophic factor and metabolic syndrome in patients with chronic schizophrenia: A systematic review.Semantic proximity
The Multidimensional Nature of Metabolic Syndrome in Schizophrenia: Lessons from Studies of One-Carbon Metabolism and DNA MethylationSemantic proximity
Metabolic syndrome in patients taking clozapine: prevalence and influence of catechol-O-methyltransferase genotype.Semantic proximity
Schizophrenia patients with a metabolically abnormal obese phenotype have milder negative symptomsSemantic proximity
Genome Wide Association Study (GWAS) Identifies Novel Genetic Loci for Second-Generation Antipsychotics (SGA)-Induced Metabolic Syndrome (MetS).Semantic proximity
Gene Polymorphisms of Hormonal Regulators of Metabolism in Patients with Schizophrenia with Metabolic Syndrome.Semantic proximity
Waist-Height ratio Highlights Detrimental Risk for Olanzapine Associated Weight Gain Earlier than Body Mass Index.Semantic proximity
Genome-wide associations with metabolic syndrome among UK Biobank participants reporting use of second-generation antipsychotics.Semantic proximity
From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids MetabolismSemantic proximity
Select a neighboring publication to make it the new centre.